Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
Date:2/9/2011

ng activities is expected to exceed $500 million.
  • Capital expenditures are expected to be approximately $125 million.  
  • Working capital management initiatives will be continued, with inventory levels increased at select international locations to support anticipated growth at those locations.

    • OTHER INFORMATION:Cash Flow and Debt:  Net cash provided by operating activities for 2010 was $523 million compared to $516 million for 2009.  This increase reflects the net effect of higher net income and non-cash charges partially offset by a smaller contribution from the Company's working capital management initiatives.  Capital expenditures were $99 million for 2010 compared to $120 million in 2009. Inventory levels were 6.3 months at December 31, 2010 compared to 6.5 months at December 31, 2009. Free cash flow of $424 million for 2010 was used to return $177 million to shareholders through share repurchases and a 10% increase in the quarterly dividend rate, repay $40 million in debt and fund acquisitions of $80 million.  The Company's debt to capital ratio was reduced to 21% at December 31, 2010 from 25% at December 31, 2009.

    Share Repurchase:  Another 0.4 million shares were acquired in the fourth quarter of 2010 at an average share price of $64.49. There were 122 million shares outstanding at December 31, 2010. The Company expects to continue to offset the dilutive impact of issuing share based incentive compensation with future repurchases. The Company may repurchase additional shares, but the timing and amount will depend upon market conditions and other factors.

    Cautionary Statement:  This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs, including phrases "is expected", "expects", "aren't likely", "seek", "should", and other statements regarding the Company'
    '/>"/>

    SOURCE Sigma-Aldrich
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Sigma-Aldrich to Present at the JP Morgan 29th Annual Healthcare Conference on Monday, January 10, 2011.
    2. Sigma-Aldrich Acquires Cerilliant Corporation to Strengthen its Analytical Chemistry Portfolio
    3. Sigma-Aldrich Corporation Announces Death of Chairman and CEO; Election of New CEO and Chairman; Conference Call Scheduled for 10:00a.m. (Central Time) on November 15, 2010
    4. Sigma-Aldrich Announces Pricing of Senior Notes
    5. Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 -
    6. Sigma-Aldrich to Present at the UBS Global Life Sciences Healthcare Conference on Tuesday, September 21, 2010
    7. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
    8. Sigma-Aldrich Corporation to Present at the Bairds 2010 Growth Stock Conference on Thursday, May 20, 2010
    9. Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll
    10. Sigma-Aldrich to Present at the Bank of America Merrill Lynch 2010 Health Care Conference on Wednesday, May 12, 2010
    11. Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
    (Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
    (Date:5/20/2013)... -- Pacific Biomarkers and Clinigene International are set to ... at the 2013 AAPS/ National Biotechnology Conference ... Marina , San Diego, ... speak with company representatives at their collaborative seminar, "Biosimilarity, ... 21 from 1-2 p.m. in the conference,s Spinnaker Room. ...
    (Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...
    Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3New Laboratory Temperature Controller by Oven Industries 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3
    ... Genetics, Inc., a privately held oncology molecular diagnostics company, ... the company,s President, Chief Executive Officer, and newest member ... Metamark co-founder who previously served as interim CEO, will ... Directors. Mr. Straley brings twenty five years ...
    ... Mass., Nov. 5, 2010 Tomophase Corporation, a leading ... imaging devices, announced that it has received an award ... Human Services for the Qualifying Therapeutic Discovery Project (QTDP.) ... a federally sponsored program that is targeted to projects ...
    ... Reports Third Quarter Financial Results ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
    Cached Biology Technology:Metamark Genetics, Inc. Announces New Chief Executive Officer 2Tomophase Receives Qualifying Therapeutic Discovery Project (QTDP) Award 2OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9OncoGenex Reports Third Quarter Financial Results 10OncoGenex Reports Third Quarter Financial Results 11OncoGenex Reports Third Quarter Financial Results 12OncoGenex Reports Third Quarter Financial Results 13
    (Date:5/19/2013)... of electricity-producing bacteria that can grow using hydrogen gas ... its sole source of carbon. Researchers at the ... 113th General Meeting of the American Society for Microbiology. ... solely on hydrogen," says Amit Kumar, a researcher on ... of the Lovley Lab Group at the university. , ...
    (Date:5/18/2013)... Orlando, FL (May 18, 2013) Research presented today ... liver disease research, with findings about the impact of ... patients. , While coffee consumption recently has been ... found that even a few more cups of java ... particular autoimmune liver disease. Researchers at the Mayo Clinic, ...
    (Date:5/17/2013)... 2013) The AGA Research Foundation announced a new ... between the gut microbiota, one of today,s most exciting ... , The AGA Research Awards Panel selected Andrew T. ... Hospital and Harvard Medical School, Boston, as the 2013 ... will receive $25,000 of funding, commencing in July 2013, ...
    Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
    ... May 7, 2012 - A new innovation can completely reshape ... of genetically engineered (GE) crops in the 1980,s ignited a ... crop yields and better nutritional content, along with the reduction ... play a significant role in the U.S., with more than ...
    ... research long-term is to develop more efficient biofuel cells, seen ... by readily available biological materials, they have the potential to ... is it not possible to replace a battery or recharge ... process glucose, but the Leeds research will focus on bacterial ...
    ... in more than 200 outlet glaciers indicates that Greenland,s contribution ... significantly less than the upper limits some scientists thought possible. ... National Science Foundation (NSF) and NASA and published in today,s ... a melting Greenland,s contributions to rising sea levels could be ...
    Cached Biology News:New research reveals challenges in genetically engineered crop regulatory process 2New research reveals challenges in genetically engineered crop regulatory process 3Creating energy from light and air - new research on biofuel cells 2Analysis of speed of Greenland glaciers gives new insight for rising sea level 2Analysis of speed of Greenland glaciers gives new insight for rising sea level 3
    Request Info...
    PGC-1 (H-300)...
    Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
    Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
    Biology Products: